Status of Airway Reactivity among Small Airway Diseases with Regular Users Substance Abuse of Inhaling Opium; Preliminary Results of a Survey of Indirect Provocation Test
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 4 No. 3(Summer) (2014),
8 September 2014
,
Page 83-90
https://doi.org/10.22037/ijmtfm.v4i3(Summer).5818
Abstract
Background:Opium is an oldest recreational abuse substance with dependency. Small airway diseases (SAD) were established within opium user’s population. Bronchial hyper-responsiveness (BHR) reflects airway reactivity and inflammation. Opium can induce airway inflammation and following airway reactivity.The objective of the study assessed status of BHR among SAD with regular inhaled opium users. It performed with hypertonic normal saline provocation challenge test.
Methods: Target population enrolled among SAD with inhaled regular opium users. In the next step, standard hypertonic normal saline provocation test carried out on the sample study.
Results:A total of 46 subjects followed the study. The mean age±SD was 50.1±1.2 years, with median 48 years. 91% of those were male. A positive result of BHR was distributed more frequently in thechronic obstructive pulmonary disease(COPD) with the asthma phenotype. In addition, it was more market in the youngest and advanced age classes equally.
Conclusion:hypertonic normal saline provocation test result was quite noticeable between regular inhaled opium users. BHR was detected more frequently in COPD with asthma phenotype, COPD, chronic bronchitis, and bronchial asthma disease, respectively. The outcome indirectly revealedthat there was a relation between airway inflammation and opium inhalation in population. It may be reflected an added effect on the predisposing risk factors of induced airway inflammation and hyperreactivity of airway in target populations.
- Opium
- Indirect Provocation Test
- Hypertonic Normal Saline
- Bronchial Hyperresponsiveness
- Small Airway Disease
How to Cite
References
Heydari M, Hashempur MH, Zargaran A. Medicinal aspects of opium as described in Avicenna's Canon of Medicine. Acta Med Hist Adriat. 2013;11(1):101-12.
http://en.wikipedia.org/wiki/Substance_abuse
Najafipour H, Mirzazadeh A, Haghdoost A, Shadkam M, Afshari M, Moazenzadeh M, et al. Coronary Artery Disease Risk Factors in an Urban and Peri-urban Setting, Kerman, Southeastern Iran (KERCADR Study): Methodology and Preliminary Report. Iran J Public Health. 2012;41(9):86-92.
Daneshpajouh M, Bahrami F, Chafii A, Kavoussi N, Pirouzmande B. Chronic pulmonary heart disease and its risk factors among a worker population in Teheran. Poumon Coeur. 1976;32(3):127-30.
Da Costa JL, Tock EP, Boey HK. Lung disease with chronic obstruction in opium smokers in Singapore. Clinical, electrocardiographic, radiological, functional and pathological features. Thorax. 1971;26(5):555-71.
Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J RespirCrit Care Med. 2003;167(3):418-24.
Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax. 2003;58(4):322-7.
Yang SC, Lin BY. Comparison of airway hyperreactivity in chronic obstructive pulmonary disease and asthma. Chang Gung Med J. 2010;33(5):515-23.
Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ. 2012;17:344.
Ranga V, Kleinerman J. Structure and function of small airways in health and disease. Arch Pathol Lab Med. 1978;102(12):609-17.
GOLD-the Global initiative for chronic Obstructive Lung Disease. Available at: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013.pdf
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. EurRespir J. 2005;26(5):948-68.
Anderson SD. Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2 Suppl):25-30.
Norn S, Kruse PR, Kruse E. History of opium poppy and morphine. Dan MedicinhistArbog. 2005;33:171-84.
Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J. 2012;9(1):18.
UNODC. World Drug Report 2011 (United Nations Publication, Sales No. E.11.XI.10) 2011.avelable at: http://www.docstoc.com/docs/130516295/World-Drug-Report-2012;
Meysamie A, Sedaghat M, Mahmoodi M, Ghodsi SM, EftekharBOpium use in a rural area of the Islamic Republic of Iran. East Mediterr Health J. 2009;15(2):425-31.
Brannan JD, Lougheed MD. Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Front Physiol. 2012;3:460.
Cockcroft DW. Direct challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2 Suppl):18-24.
Van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. EurRespir J. 2000;16(3):514-33.
Dima E, Rovina N, Gerassimou C, Roussos C, Gratziou C. Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice. Int J Chron Obstruct Pulmon Dis. 2010;5:287-96.
W. Feldberg and W. D. M. Paton. Release of histamine from skin and muscle in the cat by opium alkaloids and other histamine liberators. J Physiol. 1951;114(4):490-509.
Juusela M, Pallasaho P, Sarna S, Piirilä P, Lundbäck B, Sovijärvi A. Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV1, the main determinant. ClinRespir J. 2013;7(1):34-44.
Borges Mde C, Ferraz E, Vianna EO. Bronchial provocation tests in clinical practice. Sao Paulo Med J. 2011;129(4):243-9.
Becker EC, Wölke G, Heinrich J. Bronchial responsiveness, spirometry and mortality in a cohort of adults. J Asthma. 2013;50(4):427-32.
Solanes Garcia I, CasanClarà P. [Causes of death and prediction of mortality in COPD]. Arch Bronconeumol. 2010;46(7):343-6.
Brutsche MH, Downs SH, Schindler C, Gerbase MW, Schwartz J, Frey M, Russi EW, Ackermann-Liebrich U, Leuenberger P; SAPALDIA Team. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax. 2006;61(8):671-7.
Juusela M, Pallasaho P, Rönmark E, Sarna S, Sovijärvi A, LundbäckBDose-dependent association of smoking and bronchial hyperresponsiveness. EurRespir J. 2013.
Chinn S, Jarvis D, Luczynska CM, Ackermann-Liebrich U, Antó JM, Cerveri I, de Marco R, Gislason T, et al. An increase in bronchial responsiveness is associated with continuing or restarting smoking. Am J RespirCrit Care Med. 2005;172(8):956-61.
Dima E, Rovina N, Gerassimou C, Roussos C, Gratziou C. Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice. Int J Chron Obstruct Pulmon Dis. 2010;5:287-96.
Ghazavi A, Solhi H, Moazzeni SM, Rafiei M, Mosayebi G. Cytokine profiles in long-term smokers of opium (Taryak). J Addict Med. 2013;7(3):200-3.
Ghazavi A, Mosayebi G, Solhi H, Rafiei M, Moazzeni SM. Serum markers of inflammation and oxidative stress in chronic opium (Taryak) smokers. ImmunolLett. 2013 Jul 12. pii: S0165-2478(13)00093-X. doi: 10.1016/j.imlet.2013.07.001.
Birru RL, Di YP. Pathogenic mechanism of second hand smoke induced inflammation and COPD. Front Physiol. 2012;3:348.
Nabati S, Asadikaram G, Arababadi MK, Shahabinejad G, RezaeianM, Mahmoodi M, Kennedy D. The plasma levels of the cytokines in opium-addicts and the effects of opium on the cytokines secretion by their lymphocytes. ImmunolLett. 2013;152(1):42-6.
Feldman C, Anderson R. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect. 2013;67(3):169-84.
Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. The lung microbiome in moderate and severe chronic obstructive pulmonary disease.PLoS One. 2012;7(10):e47305.
- Abstract Viewed: 409 times
- PDF Downloaded: 128 times